ATLANTA (October 3, 2017)—Mobile telehealth and remote patient monitoring company SynsorMed Inc. has formed a strategic relationship with a leading global manufacturer of oxygen delivery equipment, CAIRE Inc., to provide medical equipment providers with the tools they need to serve their patients suffering from respiratory disease.
The multi-year agreement combines SynsorMed’s innovative technology to monitor patient conditions outside of the hospital with CAIRE’s portable and stationary oxygen therapy devices. The new mobile solution will be branded as “CAIREview powered by SynsorMed.”
"SynsorMed is an emerging leader in patient engagement for preventing hospital readmissions and it was only natural that we are teaming up with an established company like CAIRE to create a system designed to help encourage patient compliance,” Theo Harvey, Chief Executive Officer of SynsorMed.
“CAIREview powered by SynsorMed is another milestone within the deep legacy of innovation for our brand,” said Earl Lawson, president of Chart’s BioMedical group. “It is also an outward sign of our commitment to enhancing our portfolio of oxygen therapy solutions to include features and benefits our providers can depend on to serve their oxygen patients.”
Available on Android and iOS platforms, SynsorMed integrates with FDA approved devices to provide analyses on patients’ oxygen concentrators wherever they are.
“In the first phase, our B2B customers will be able to connect and monitor a patient’s oxygen concentrator from a customized dashboard which can remotely monitor device alarms and general diagnostics thanks to an app on the patient’s phone and Bluetooth technology,” said Dan Van Hise, Vice President of Marketing for Chart’s BioMedical Group.
According to a report by The Advisory Board Company, “remote patient monitoring technologies increase patient access, improve outcomes, and reduce costs for patients with chronic conditions.”
“We strongly believe our innovative machine learning algorithms and internet of things—enabled platform create a more interactive and immersive experience for CAIRE’s clients and will go a long way toward generating better overall health outcomes,” said Amin Holmes, chief technical officer of SynsorMed.
The telehealth market is projected to be a $9 billion global industry by 2021 because of the increased need of health care providers to take a greater role in remote monitoring patients who suffer from chronic conditions.
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in the US, according to the American Lung Association. Because more than 11 million people have been diagnosed with COPD and millions may have the disease without knowing it, health care leaders are working to increase ways they can work with patients to monitor their health, or use of a medical device, like an oxygen concentrator, as part of disease management programs put into place by their physicians to help prevent costly hospital readmissions.
Visit cairemedical.com and synsormed.com for more information.
